<?xml version="1.0" encoding="UTF-8"?>
<p id="para0009">This study was a retrospective multicentre investigation hosted by the MucoMicrobes working group and was approved by the ethics committee at the Brest Teaching Hospital (CHRU of Brest, France). CF patients were recruited from three French CF centres: CHU of Angers (centre A); Roscoff (centre B), and Foch Hospital, Paris-Suresnes (centre C). These patients were retrospectively enrolled between February 2016 and February 2017 based on the following inclusion criteria: patients with a confirmed diagnosis of CF, adults or children regardless of their age, able to expectorate, with signs of acute lower or upper respiratory tract infection, during a consultation or while hospitalised.</p>
